US Patent 9365642 Methods and compositions for targeting polyubiquitin
Patent 9365642 was granted and assigned to Genentech on June, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+119 characters)
Article
Patent abstract
Anti-K63-linked polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09365642 Methods and compositions for targeting polyubiquitin US Patent 9365642 Methods and compositions for targeting polyubiquitin
Infobox
Patent Number
0936564200
Patent Number
936564200
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093656420
Date of Patent
June 14, 2016
0Patent Application Number
147322430
Date Filed
June 5, 2015
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093656420
Date of Patent
June 14, 2016
0Patent Application Number
147322430
Date Filed
June 5, 2015
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09365642 Methods and compositions for targeting polyubiquitin
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09365642
Date of patent
June 14, 2016
Patent application number
14732243
Date Filed
June 5, 2015
Patent primary examiner
Find more entities like US Patent 9365642 Methods and compositions for targeting polyubiquitin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
